Steris PLC (STE)
219.54
+3.10
(+1.43%)
USD |
NYSE |
Jun 28, 16:00
219.57
+0.03
(+0.01%)
After-Hours: 20:00
Steris Research and Development Expense (Annual): 103.68M for March 31, 2024
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2024 | 103.68M |
| March 31, 2023 | 98.48M |
| March 31, 2022 | 86.66M |
| March 31, 2021 | 66.33M |
| March 31, 2020 | 65.55M |
| March 31, 2019 | 63.04M |
| March 31, 2018 | 60.78M |
| March 31, 2017 | 59.40M |
| March 31, 2016 | 56.66M |
| March 31, 2015 | 54.14M |
| March 31, 2014 | 48.64M |
| March 31, 2013 | 41.30M |
| March 31, 2012 | 35.95M |
| March 31, 2011 | 34.28M |
| March 31, 2010 | 34.01M |
| Date | Value |
|---|---|
| March 31, 2009 | 32.76M |
| March 31, 2008 | 36.92M |
| March 31, 2007 | 33.63M |
| March 31, 2006 | 33.60M |
| March 31, 2005 | 31.51M |
| March 31, 2004 | 27.62M |
| March 31, 2003 | 25.52M |
| March 31, 2002 | 21.71M |
| March 31, 2001 | 23.98M |
| March 31, 2000 | 24.17M |
| March 31, 1999 | 24.80M |
| March 31, 1998 | 23.90M |
| March 31, 1997 | 22.00M |
| March 31, 1996 | 17.90M |
| March 31, 1995 | 17.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
65.55M
Minimum
2020
103.68M
Maximum
2024
84.14M
Average
86.66M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Edwards Lifesciences Corp | 1.072B |
| ResMed Inc | 287.64M |
| Align Technology Inc | 346.83M |
| NeuroOne Medical Technologies Corp | 6.941M |
| Nutriband Inc | 1.960M |